nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints
|
Fumagalli, Debora |
|
2012 |
13 |
6 |
p. e240-e248 nvt p. |
artikel |
2 |
Addiction Incorporated
|
Burki, Talha Khan |
|
2012 |
13 |
6 |
p. 577- 1 p. |
artikel |
3 |
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
|
Burmeister, Bryan H |
|
2012 |
13 |
6 |
p. 589-597 9 p. |
artikel |
4 |
A new drug for Hodgkin's lymphoma
|
Sharma, Sharan Prakash |
|
2012 |
13 |
6 |
p. e236- 1 p. |
artikel |
5 |
Avoiding stem cells could spare salivary gland function
|
Senior, Kathryn |
|
2012 |
13 |
6 |
p. e239- 1 p. |
artikel |
6 |
Be clear on good health
|
Jouret, Jill |
|
2012 |
13 |
6 |
p. 575- 1 p. |
artikel |
7 |
Brachytherapy versus total breast radiation
|
Brower, Vicki |
|
2012 |
13 |
6 |
p. e236- 1 p. |
artikel |
8 |
BRCA1 mutations increase risk of prostate cancer
|
Bennet, Neil |
|
2012 |
13 |
6 |
p. e233- 1 p. |
artikel |
9 |
Canadian cuts overshadow good news on cancer statistics
|
Senior, Kathryn |
|
2012 |
13 |
6 |
p. 572- 1 p. |
artikel |
10 |
Cancer detection and primary care…revisited
|
The Lancet Oncology, |
|
2012 |
13 |
6 |
p. 559- 1 p. |
artikel |
11 |
Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden
|
Ji, Jianguang |
|
2012 |
13 |
6 |
p. 642-648 7 p. |
artikel |
12 |
Capecitabine in the treatment of rectal cancer
|
Beets, Geerard L |
|
2012 |
13 |
6 |
p. 560-561 2 p. |
artikel |
13 |
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
|
Hofheinz, Ralf-Dieter |
|
2012 |
13 |
6 |
p. 579-588 10 p. |
artikel |
14 |
Chinese miners at increased risk of cancer
|
Burki, Talha Khan |
|
2012 |
13 |
6 |
p. e232- 1 p. |
artikel |
15 |
Correction to Lancet Oncol 2012; 13: 569
|
|
|
2012 |
13 |
6 |
p. e231- 1 p. |
artikel |
16 |
Cut Poison Burn
|
Yaqub, Farhat |
|
2012 |
13 |
6 |
p. 578- 1 p. |
artikel |
17 |
3D histopathology could help cancer research and treatment
|
Bennet, Neil |
|
2012 |
13 |
6 |
p. e234- 1 p. |
artikel |
18 |
Exploring the limits in low rectal cancer
|
Moran, Brendan |
|
2012 |
13 |
6 |
p. 565-567 3 p. |
artikel |
19 |
Faster access to Cancer Drugs Fund
|
Tanday, Sanjay |
|
2012 |
13 |
6 |
p. e234- 1 p. |
artikel |
20 |
Fertility drugs and childhood leukaemia: is there a link?
|
Burki, Talha Khan |
|
2012 |
13 |
6 |
p. e235- 1 p. |
artikel |
21 |
Finally, a substantial role for radiotherapy in melanoma
|
Macklis, Roger |
|
2012 |
13 |
6 |
p. 561-562 2 p. |
artikel |
22 |
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
|
Ahmed, Hashim U |
|
2012 |
13 |
6 |
p. 622-632 11 p. |
artikel |
23 |
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
|
de Martel, Catherine |
|
2012 |
13 |
6 |
p. 607-615 9 p. |
artikel |
24 |
Global burden of infection-related cancer revisited
|
Danaei, Goodarz |
|
2012 |
13 |
6 |
p. 564-565 2 p. |
artikel |
25 |
Helping GPs to diagnose cancer earlier
|
Senior, Kathryn |
|
2012 |
13 |
6 |
p. e232- 1 p. |
artikel |
26 |
Home from Home
|
Burki, Talha Khan |
|
2012 |
13 |
6 |
p. 576- 1 p. |
artikel |
27 |
HPV vaccine dropoff fear
|
Wilkinson, Emma |
|
2012 |
13 |
6 |
p. e237- 1 p. |
artikel |
28 |
Lenalidomide maintenance for multiple myeloma
|
Brower, Vicki |
|
2012 |
13 |
6 |
p. e238- 1 p. |
artikel |
29 |
Low-dose radioiodine ablation for thyroid cancer
|
Bennet, Neil |
|
2012 |
13 |
6 |
p. e237- 1 p. |
artikel |
30 |
Lynch syndrome: new tales from the crypt
|
Boland, C Richard |
|
2012 |
13 |
6 |
p. 562-564 3 p. |
artikel |
31 |
microRNAs in cancer management
|
Kong, Yi W |
|
2012 |
13 |
6 |
p. e249-e258 nvt p. |
artikel |
32 |
mTOR inhibition in hormone-resistant breast cancer
|
Sharma, Sharan Prakash |
|
2012 |
13 |
6 |
p. e239- 1 p. |
artikel |
33 |
New treatment options in advanced bladder cancer
|
Brower, Vicki |
|
2012 |
13 |
6 |
p. e233- 1 p. |
artikel |
34 |
NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen
|
Jilani, Anwar |
|
2012 |
13 |
6 |
p. 573-574 2 p. |
artikel |
35 |
Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy
|
Hoffman, Karen E |
|
2012 |
13 |
6 |
p. e270-e276 nvt p. |
artikel |
36 |
Personalised medicine in nasopharyngeal cancer
|
Toh, Han Chong |
|
2012 |
13 |
6 |
p. 568-569 2 p. |
artikel |
37 |
Polyglutamine diseases and the risk of cancer
|
Pouladi, Mahmoud A |
|
2012 |
13 |
6 |
p. 569-571 3 p. |
artikel |
38 |
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial
|
Fujita, Shin |
|
2012 |
13 |
6 |
p. 616-621 6 p. |
artikel |
39 |
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study
|
Kloor, Matthias |
|
2012 |
13 |
6 |
p. 598-606 9 p. |
artikel |
40 |
Priorities for cancer prevention
|
Page, Jamie |
|
2012 |
13 |
6 |
p. e230- 1 p. |
artikel |
41 |
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
|
Liu, Na |
|
2012 |
13 |
6 |
p. 633-641 9 p. |
artikel |
42 |
Prostate cancer treatment unblinded
|
Tsivian, Matvey |
|
2012 |
13 |
6 |
p. 567-568 2 p. |
artikel |
43 |
Second-line everolimus treatment in advanced renal-cell cancer
|
Brower, Vicki |
|
2012 |
13 |
6 |
p. e235- 1 p. |
artikel |
44 |
Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?
|
Zumsteg, Zachary S |
|
2012 |
13 |
6 |
p. e259-e269 nvt p. |
artikel |
45 |
Voices from the front: June
|
Mastrianni, David M |
|
2012 |
13 |
6 |
p. 578- 1 p. |
artikel |